WATERTOWN, Mass., Feb. 14, 2023 (GLOBE NEWSWIRE) — Disc Drugs, Inc. (NASDAQ: IRON) a clinical-stage biopharmaceutical firm targeted on the invention, growth and commercialization of novel therapies for sufferers affected by critical hematologic ailments,...